Organic & Biomolecular Chemistry
Page 8 of 9
dichloride (assumed quantitative conversion) was immediately dissolved in dry
CH2Cl2 (30 mL) and added dropwise to solution of bis-amine (600 mg,
-CH2-N3), 4.02 (2H, t, 3J = 5.6 Hz, O-CH2-CH2), 2.84 (3H, s, NC-CH3), 2.37–2.42
a
6
(2H, m, CH2-CH2-CH2), 1.30 (27H, s, -tBu). 13C NMR (75.5 MHz, CDCl3) (ppm)
155.7, 148.4, 144.1, 144.0, 141.3, 140.4, 139.8, 134.9, 132.4, 132.0, 130.6, 128.8,
75 128.7, 128.0, 127.5, 124.1, 122.3, 121.8, 112.8, 63.5, 63.0, 54.4, 52.1, 45.9, 34.3,
1.48 mmol) and Et3N (0.52 mL, 3.71 mmol) in dry CH2Cl2 (75 mL) which had been
stirred for 30 min. The reaction mixture was then stirred at room temperature under
5 N2(g) for 2 h, after which time the solution was washed with 10% HCl(aq) (2 x 50 mL)
and H2O (2 x 50 mL) and dried over MgSO4. The solvent was removed in vacuo and
purified by silica gel column chromatography using 97:3 CH2Cl2/MeOH followed
by 7:3 CHCl3/acetone to elute the product as a white solid (117 mg, 0.20 mmol,
13%). Procedure B: Same as A, but with 2-methylimidazolium thread 2·Cl (425 mg,
10 1.48 mmol) added at the same time as bis-amine 6, yielding the product as described
above (280 mg, 0.47 mmol, 32%). Mp > 250 °C. 1H NMR (300 MHz, CDCl3)
(ppm) 8.04 (2H, s, Hb), 7.82 (1H, s, Hc), 7.15 (4H, d, 3J = 8.2 Hz, Hf), 6.69 (4H, d,
3J = 8.2 Hz, Hg), 6.47 (2H, br s, Hd), 4.51 (4H, d, 3J = 5.3 Hz, He), 3.97–4.02 (4H, m,
Hh), 3.77–3.80 (4H, m, Hi), 3.67–3.69 (8H, m, Hj & Hk), 1.30 (9H, s, Ha). 13C NMR
15 (75.5 MHz, CDCl3) (ppm) 166.8, 157.9, 152.6, 133.8, 130.3, 129.5, 128.4, 120.7,
114.5, 70.7, 69.6, 67.2, 43.8, 35.0, 31.1 (one peak missing – coincidental). MS-ESI
31.3, 29.2, 10.8 (one peak missing
– coincidental). MS-ESI m/z 848.5257
([M − Cl]+, C58H66N5O, calc. 848.5262), 848.5 ([M − Cl]+) – only observed peak in
low resolution mass spectrum.
Rotaxane 13·PF6. To a solution of macrocycle 4 (67 mg, 0.113 mmol), azide 11·Cl
80 (100 mg, 0.113 mmol) and alkyne 12 (74 mg, 0.136 mmol) in dry CH2Cl2 (25 mL)
was added TBTA (6 mg, 0.011 mmol) and DIPEA (39 l, 0.226 mmol) followed by
Cu(MeCN)4PF6 (8 mg, 0.023 mmol). The reaction mixture was stirred under N2(g)
for 72 h and then the solvent removed in vacuo. Purification was undertaken by
preparative silica gel thin layer chromatography using 94:6 CH2Cl2/MeOH. The
85 crude product was dissolved in CH2Cl2 (10 mL), washed with 0.1 M NH4PF6(aq)
(10 x 5 mL) and H2O (4 x 5 mL), and dried over MgSO4. The solvent was removed
was then removed in vacuo and the residue triturated with methanol (3 x 3 mL) to
yield the product as an off-white solid (36 mg, 0.017 mmol, 15%). 1H NMR
m/z 613.2896 ([M
+
Na]+, C34H42N2NaO7, calc. 613.2884), 613.3 (100%,
[M + Na]+), 1203.7 (15%, [2M + Na]+); 625.3 (50%, [M + Cl]−), 703.3 (100%,
[M + CF3COO]−), 625.3 (30%, [2M + Cl]−).
(500 MHz, CDCl3) (ppm) 8.22 (2H, d, 3J = 1.5 Hz, Hb), 7.53–7.63 (7H, m, Hc
&
90 Hd & H14 & H15), 7.34 (2H, d, 3J = 7.8 Hz, H16), 7.20–7.26 (15H, m, H2 & H13 & H18
& H23), 7.13–7.18 (6H, m, Hf & H4), 7.06–7.11 (15H, m, H3 & H11 & H21 & H22),
6.95 (1H, d, 3J = 2.0 Hz, H10), 6.82 (2H, d, 3J = 8.8 Hz, H20), 6.73 (2H, d,
3J = 8.8 Hz, H5), 6.22 (4H, d, 3J = 8.3 Hz, Hg), 5.49 (2H, s, H17), 5.02 (2H, s, H19),
4.94 (2H, s, H12), 4.60 (2H, d, 2J = 13.2 Hz, He’), 4.38 (2H, d, 2J = 13.2 Hz, He”),
95 3.81–3.85 (2H, m, H6), 3.72–3.77 (2H, m, H8), 3.57–3.67 (12H, m, Hi & Hj & Hk),
3.50–3.55 (2H, m, Hh’), 3.44–3.48 (2H, m, Hh”), 1.99–2.02 (3H, m, H9), 1.87–1.92
(2H, m, H7), 1.31 (9H, s, Ha), 1.26 (27H, s, H1 or H24), 1.26 (27H, s, H1 or H24).
19F NMR (282.5 MHz, CDCl3) (ppm) − 71.8 (d, 1J = 714 Hz, PF6). 13C NMR
(125.8 MHz, CDCl3) (ppm) 167.6, 156.8, 156.1, 156.0, 152.2, 148.4, 148.3, 144.0,
20 Rotaxane 8·Cl. 5-Nitroisophthalic acid (14 mg, 0.066 mmol) was suspended in
SOCl2 (1 mL) and heated at reflux under N2(g) for 15 h. The excess SOCl2 was then
removed by distillation, and the residue dried in vacuo. The crude dichloride
(assumed quantitative conversion) was immediately dissolved in dry CH2Cl2 (5 mL)
and added dropwise to a solution of bis-amine 6 (27 mg, 0.066 mmol), axle 7·Cl
25 (80 mg, 0.066 mmol) and Et3N (23 L, 0.166 mmol) in dry CH2Cl2 (13 mL) which
had been stirred for 30 min. The reaction mixture was then stirred at room
temperature under N2(g) for 2 h, after which time the solution was washed with 10%
HCl(aq) (2 x 10 mL) and H2O (2 x 10 mL) and dried over MgSO4. The solvent was
removed in vacuo and the residue purified by preparative silica gel thin layer 100 142.9, 141.4, 140.5, 140.4, 140.2, 134.2, 134.1, 133.9, 132.4, 132.3, 131.7, 130.7,
30 chromatography (1:1 CH2Cl2/MeCN followed by 96:4 CH2Cl2/MeOH) to yield the
product as an off-white solid (5 mg, 0.003 mmol, 4%). Mp 183–185 °C (dec.).
1H NMR (500 MHz, CDCl3) (ppm) 9.78 (2H, br s, Hc), 9.23 (1H, br s, Hb), 9.01
(2H, s, Ha), 7.38 (2H, s, H1), 7.27–7.30 (4H, m, He), 7.23–7.26 (12H, m, H9), 7.17
130.6, 130.3, 129.9, 128.8, 128.5, 128.0, 127.9, 124.1, 124.0, 122.7, 122.1, 120.5,
113.2, 113.1, 112.9, 71.2, 70.7, 70.0, 66.8, 64.1, 63.1, 62.0, 53.9, 51.4, 45.4, 42.0,
35.0, 34.3, 31.4, 31.2, 29.7, 29.1, 8.9 (five peaks missing – coincidental). MS-ESI
m/z 1002.5831 ([M − PF6 + Na]2+, C132H154N7NaO9, calc. 1002.5864), 1002.6 (85%,
(4H, d, 3J = 8.8 Hz, H7), 7.09–7.12 (12H, m, H8), 6.79 (4H, d, 3J = 8.8 Hz, H6), 6.36 105 [M − PF6 + Na]2+), 1981.9 (100%, [M − PF6]+).
35 (4H, d, 3J = 8.8 Hz, Hf), 4.61–4.65 (4H, m, Hd), 3.98–4.00 (4H, m, H5), 3.90–3.93
(4H, m, H3), 3.57–3.65 (12H, m, Hh & Hi & Hj), 3.48–3.51 (4H, m, Hg), 2.04–2.09
Axle 14·PF6. Isolated from the reaction mixture for the preparation of rotaxane
(4H, m, H4), 1.66 (3H, s, H2), 1.27 (54H, s, H10). 13C NMR (125.8 MHz, CDCl3)
(ppm) 164.9, 157.1, 156.0, 149.0, 148.4, 144.0, 143.4, 140.1, 136.4, 133.6, 132.4,
130.6, 130.4, 126.2, 124.1, 121.5, 113.1, 112.9, 71.1, 70.5, 67.8, 66.7, 64.3, 63.1,
40 53.4, 45.8, 42.3, 34.3, 31.4, 8.0 (one peak missing – coincidental). MS-ESI m/z
1752.0318 ([M − Cl]+, C114H136N5O11, calc. 1752.0264), 1751.9 ([M − Cl]+) – only
observed peak in low resolution mass spectrum.
13·PF6 as a white solid. 1H NMR (500 MHz, CDCl3) (ppm) 7.56–7.59 (3H, m, H14
& H18), 7.53 (2H, d, 3J = 8.1 Hz, H15), 7.34 (2H, d, 3J = 8.1 Hz, H16), 7.30 (2H, d,
3J = 8.1 Hz, H13), 7.21–7.24 (13H, m, H2 & H11 & H23), 7.19 (1H, s, H10), 7.03–7.11
110 (16H, m, H3 & H4 & H21 & H22), 6.83 (2H, d, 3J = 8.8 Hz, H20), 6.68 (2H, d,
3J = 9.3 Hz, H5), 5.56 (2H, s, H17), 5.24 (2H, s, H12), 5.15 (2H, s, H19), 4.33 (2H, t,
3J = 6.6 Hz, H8), 3.96 (2H, t, 3J = 5.4 Hz, H6), 2.62 (3H, s, H9), 2.24–2.29 (2H, m,
H7), 1.26 (27H, s, H1 or H24), 1.25 (27H, s, H1 or H24). 19F NMR (282.5 MHz,
CDCl3) (ppm) − 73.3 (d, 1J = 713 Hz, PF6). 13C NMR (75.5 MHz, CDCl3) (ppm)
Thread 10·Cl. Imidazole derivative
9
(300 mg, 0.48 mmol) and
4,4’-bis(chloromethyl)-1,1’-biphenyl (600 mg, 0.68 mmol) were dissolved in 115 156.1, 155.7, 148.4, 148.3, 144.8, 144.2, 144.0, 143.9, 141.1, 140.4, 140.4, 140.2,
45 acetone (30 mL) and heated under microwave irradiation at 150 °C for 2 h. The
solvent was then removed in vacuo and the residue purified by silica gel gradient
column chromatography using 95:5 to 85:15 CH2Cl2/MeOH to elute the product as a
134.0, 132.4, 132.3, 132.0, 130.7, 130.6, 128.8, 128.7, 128.1, 127.8, 124.1, 124.0,
122.6, 122.1, 121.7, 113.1, 112.8, 63.5, 63.0, 62.0, 53.8, 52.1, 45.9, 34.3, 31.4, 29.2,
10.9 (three peaks missing – coincidental). MS-ESI m/z 1391.8887 ([M − PF6]+,
C98H112N5O2, calc. 1391.8843), 1391.8 (100%, [M − PF6]+) – only observed peak in
white solid (353 mg, 0.40 mmol, 84%). Mp
>
250 °C. 1H NMR (300 MHz,
CDCl3) (ppm) 7.62 (1H, d, 3J = 2.4 Hz, NC-H), 7.57 (2H, d, 3J = 8.0 Hz, Ar-H), 120 low resolution mass spectrum.
50 7.54 (1H, d, 3J = 2.4 Hz, NC-H), 7.51 (2H, d, 3J = 8.0 Hz, Ar-H), 7.44 (2H, d,
3J = 8.0 Hz, Ar-H), 7.40 (2H, d, 3J = 8.0 Hz, Ar-H), 7.20–7.26 (6H, m, Ar-H), 7.03–
Acknowledgements
7.11 (8H, m, Ar-H), 6.67 (2H, d, 3J = 8.8 Hz, OAr-H), 5.57 (2H, s, N-CH2-Ar), 4.63
(2H, s, -CH2-Cl), 4.51 (2H, t, 3J = 6.5 Hz, N-CH2-CH2), 4.02 (2H, t, 3J = 5.6 Hz,
O-CH2-CH2), 2.84 (3H, s, NC-CH3), 2.37–2.41 (2H, m, CH2-CH2-CH2), 1.30 (27H,
55 s, -tBu). 13C NMR (75.5 MHz, CDCl3) (ppm) 155.7, 148.3, 144.1, 143.9, 141.2,
140.4, 139.9, 137.0, 132.4, 132.1, 130.6, 129.1, 128.8, 128.0, 127.3, 124.0, 122.3,
121.8, 112.8, 63.6, 63.0, 52.0, 50.6, 45.8, 34.2, 31.3, 29.2, 10.8 (one peak missing –
coincidental). MS-ESI m/z 841.4869 ([M − Cl]+, C58H66ClN2O, calc. 841.4858),
841.4 ([M − Cl]+) – only observed peak in low resolution mass spectrum.
G.T.S. thanks the EPSRC for a studentship (EP/F011504).
N.G.W. thanks the Clarendon Fund and Trinity College for a
studentship, and the Oxford University Crystallography Service
125 for instrument use. We are grateful to Diamond Light Source for
an award of beamtime on Beamline I19.
60 Thread 11·Cl. Imidazolium 10·Cl (350 mg, 0.40 mmol) and NaN3 (78 mg,
1.20 mmol) were dissolved in DMF (15 mL) and heated at 80 °C under N2(g) for
15 h. After this time, H2O (40 mL) was added and the crude product extracted with
CH2Cl2 (3 x 50 mL). The combined organic fractions were washed with H2O
(1 x 20 mL), dried over MgSO4 and the solvent removed in vacuo. The resulting
65 residue was dissolved in CH2Cl2 (15 mL), washed with 1.0 M NH4Cl(aq) (5 x 10 mL),
H2O (2 x 10 mL) and brine (1 x 10 mL), and dried over MgSO4. The solvent was
then removed in vacuo to yield the product as a white solid (306 mg, 0.35 mmol,
87%). Mp > 250 °C. 1H NMR (300 MHz, CDCl3) (ppm) 7.64 (1H, d, 3J = 2.3 Hz,
NC-H), 7.51–7.60 (5H, m, 2 x Ar-H & NC-H), 7.35–7.42 (4H, m, 2 x Ar-H), 7.20–
70 7.26 (6H, m, Ar-H), 7.03–7.11 (8H, m, Ar-H), 6.68 (2H, d, 3J = 8.8 Hz, OAr-H),
5.58 (2H, s, N-CH2-Ar), 4.51 (2H, t, 3J = 6.8 Hz, N-CH2-CH2), 4.39 (2H, s,
Notes and references
a Chemistry Research Laboratory, Department of Chemistry, University
of Oxford, Mansfield Road, Oxford OX1 3TA, UK. Fax: +44 (0) 1865
130 272609; Tel: +44 (0) 1865 285142; E-mail: paul.beer@chem.ox.ac.uk
† Electronic Supplementary Information (ESI) available: spectral
characterisation of novel compounds, 2D 1H-1H ROESY spectra, 1H
NMR titration protocols and data, discussion of pseudorotaxane
equilibria, and crystallographic information. See DOI: 10.1039/b000000x/
135 ‡ With the same objective of optimising the properties of functional
interlocked structures through strategic design modifications, the effect of
8
| Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]